CBP recruitment and histone acetylation in differential gene induction by glucocorticoids and progestins

Molecular Endocrinology

Volumn 17, Issue 6, 2003, Pages 1085-1094

  Lambert, James R ^a   Nordeen, Steven K ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DEXAMETHASONE; GESTAGEN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HISTONE; HISTONE H3; HISTONE H4; LUCIFERASE; PROGESTERONE RECEPTOR; PROMEGESTONE;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL LINE; CHROMATIN; CHROMOSOME; CONTROLLED STUDY; GENE ACTIVATION; GENE INDUCTION; GENE LOCUS; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN METABOLISM; RECEPTOR BINDING; TRANSCRIPTION REGULATION;

ACETYLATION; ANIMALS; CHROMATIN; CREB-BINDING PROTEIN; GENE EXPRESSION REGULATION; HISTONES; MAMMARY TUMOR VIRUS, MOUSE; MICE; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; ONCOVIRINAE;

EID: 0037503874     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2001-0183     Document Type: Article

References (60)

1. Wolffe AP, Kurumizaka H 1998 The nucleosome: a powerful regulator of transcription. Prog Nucleic Acid Res Mol Biol. 61:379-422
2. Durrin LK, Mann RK, Kayne PS, Grunstein M 1991 Yeast histone H4 N-terminal sequence is required for promoter activation in vivo. Cell 65:1023-1031
3. Mann RK, Grunstein M 1992 Histone H3 N-terminal mutations allow hyperactivation of the yeast GAL1 gene in vivo. EMBO J 11:3297-3306
4. Strahl BD, Allis CD 2000 The language of covalent histone modifications. Nature 403:41-45
5. Hong L, Schroth GP, Matthews HR, Yau P, Bradbury EM 1993 Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA. J Biol Chem 268:305-314
6. Allfrey VG, Faulkner R, Mirsky AE 1964 Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 51:786-794
7. Hebbes TR, Thorne AW, Crane-Robinson C 1988 A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J 7:1395-1402
8. Grunstein M 1997 Histone acetylation in chromatin structure and transcription. Nature 389:349-352
9. Struhl K 1998 Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12:599-606
10. Jeppesen P, Turner BM 1993 The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression. Cell 74:281-289
11. Deckert J, Struhl K 2001 Histone acetylation at promoters is differentially affected by specific activators and repressors. Mol Cell Biol 21:2726-2735
12. Jenster G 1998 Coactivators and corepressors as mediators of nuclear receptor function: an update. Mol Cell Endocrinol 143:1-7
13. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
14. Glass CK, Rose DW, Rosenfeld MG 1997 Nuclear receptor coactivators. Curr Opin Cell Biol 9:222-232
15. Lemon BD, Freedman LP 1999 Nuclear receptor cofactors as chromatin remodelers. Curr Opin Genet Dev 9:499-504
16. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1997 Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198
17. Bannister AJ, Kouzarides T 1996 The CBP co-activator is a histone acetyltransferase. Nature 384:641-643
18. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM 1997 Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380
19. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG 1997 A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48
20. Alland L, Muhle R, Hou Jr H, Potes J, Chin L, Schreiber-Agus N, DePinho RA 1997 Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55
21. DiRenzo J, Shang Y, Phelan M, Sif S, Myers M, Kingston R, Brown M 2000 BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol 20:7541-7549
22. Sewack GF, Ellis TW, Hansen U 2001 Binding of TATA binding protein to a naturally positioned nucleosome is facilitated by histone acetylation. Mol Cell BioL 21:1404-1415
23. Kim MY, Hsiao SJ, Kraus WL 2001 A role for coactivators and histone acetylation in estrogen receptor α-mediated transcription initiation. EMBO J 20:6084-6094
24. Sun JM, Chen HY, Davie JR 2001 Effect of estradiol on histone acetylation dynamics in human breast cancer cells. J Biol Chem 276:49435-49442
25. Chandler VL, Maler BA, Yamamoto KR 1983 DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo. Cell 33:489-499
26. Scheidereit C, Beato M 1984 Contacts between hormone receptor and DNA double helix within a glucocorticoid regulatory element of mouse mammary tumor virus. Proc Natl Acad Sci USA 81:3029-3033
27. Majors J, Varmus HE 1983 A small region of the mouse mammary tumor virus long terminal repeat confers glucocorticoid hormone regulation on a linked heterologous gene. Proc Natl Acad Sci USA 80:5866-5870
28. Cato AC, Miksicek R, Schutz G, Arnemann J, Beato M 1986 The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction. EMBO J 5:2237-2240
29. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275
30. Ham J, Thomson A, Needham M, Webb P, Parker M 1988 Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acids Res 16:5263-5276
31. Darbre P, Page M, King RJ 1986 Androgen regulation by the long terminal repeat of mouse mammary tumor virus. Mol Cell Biol 6:2847-2854
32. Cato AC, Henderson D, Ponta H 1987 The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO J 6:363-368
33. Bartsch J, Truss M, Bode J, Beato M 1996 Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure. Proc Natl Acad Sci USA 93:10741-10746
34. Bresnick EH, John S, Berard DS, LeFebvre P, Hager GL 1990 Glucocorticoid receptor-dependent disruption of a specific nucleosome on the mouse mammary tumor virus promoter is prevented by sodium butyrate. Proc Natl Acad Sci USA 87:3977-3981
35. Sheldon LA, Becker M, Smith CL 2001 Steroid hormone receptor-mediated histone deacetylation and transcription at the mouse mammary tumor virus promoter. J Biol Chem 276:32423-32426
36. Wilson MA, Ricci AR, Droo BJ, Archer TK 2002 The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo. J Biol Chem 277:15171-15181
37. Lambert JR, Nordeen SK 1998 Steroid-selective initiation of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter is controlled by the site of promoter integration. J Biol Chem 273:32708-32714
38. Nordeen SK, Kuhnel B, Lawler-Heavner J, Barber DA, Edwards DP 1989 A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line. Mol Endocrinol 3:1270-1278
39. Chen H, Lin RJ, Xie W, Wilpitz D, Evans RM 1999 Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98:675-686
40. Richard-Foy H, Hager GL 1987 Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J 6:2321-2328
41. Smith CL, Hager GL 1997 Transcriptional regulation of mammalian genes in vivo. A tale of two templates. J Biol Chem 272:27493-27496
42. Mahadevan LC, Willis AC, Barratt MJ 1991 Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell 65:775-783
43. Thomson S, Mahadevan LC, Clayton AL 1999 MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction. Semin Cell Dev Biol 10:205-214
44. Chadee DN, Hendzel MJ, Tylipski CP, Allis CD, Bazett-Jones DP, Wright JA, Davie JR 1999 Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibrobLasts. J Biol Chem 274:24914-24920
45. Nowak SJ, Corces VG 2000 Phosphorylation of histone H3 correlates with transcriptionally active loci. Genes Dev 14:3003-3013
46. Trivier E, De Cesare D, Jacquot S, Pannetier S, Zackai E, Young I, Mandel JL, Sassone-Corsi P, Hanauer A 1996 Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 384:567-570
47. Sassone-Corsi P, Mizzen CA, Cheung P, Crosio C, Monaco L, Jacquot S, Hanauer A, Allis CD 1999 Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 285:886-8891
48. De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P 1998 Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci USA 95:12202-12207
49. Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW, Stallcup MR 1999 Regulation of transcription by a protein methyltransferase. Science 284:2174-2177
50. Chen D, Huang SM, Stallcup MR 2000 Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300. J Biol Chem 275:40810-40816
51. Koh SS, Chen D, Lee YH, Stallcup MR 2001 Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem 276:1089-1098
52. Schurter BT, Koh SS, Chen D, Bunick GJ, Harp JM, Hanson BL, Henschen-Edman A, Mackay DR, Stallcup MR, Aswad DW 2001 Methylation of histone h3 by coactivator-associated arginine methyltransferase 1. Biochemistry 40:5747-5756
53. Ma H, Baumann CT, Li H, Strahl BD, Rice R, Jelinek MA, Aswad DW, Allis CD, Hager GL, Stallcup MR 2001 Hormone-dependent, CARM1-directed, arginine-specific methylation of histone H3 on a steroid-regulated promoter. Curr Biol 11:1981-1985
54. Wang H, Huang ZQ, Xia L, Feng Q, Erdjument-Bromage H, Strahl BD, Briggs SD, Allis CD, Wong J, Tempst P, Zhang Y 2001 Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293:853-857
55. Jiang W, Nordeen SK, Kadonaga JT 2000 Transcriptional analysis of chromatin assembled with purified ACF and dNAP1 reveals that acetyl-CoA is required for preinitiation complex assembly. J Biol Chem 275:39819-39822
56. Dilworth FJ, Fromental-Ramain C, Yamamoto K, Chambon P 2000 ATP-Driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR in vitro. Mol Cell 6:1049-1058
57. Kundu TK, Palhan VB, Wang Z, An W, Cole PA, Roeder R 2000 Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol Cell 6:551-561
58. Nordeen SK 1988 Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6:454-458
59. Wigler M, Pellicer A, Silverstein S, Axel R, Urlaub G, Chasin L 1979 DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci USA 76:1373-1376
60. Archer TK, Zaniewski E, Moyer ML, Nordeen SK 1994 The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells. Mol Endocrinol 8:1154-1162